Search
for
Sort by
Research 301–330 of 777
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Poster Presentations
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Alopecia areata – Current understanding and management
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Treatments for alopecia areata: a network meta-analysis
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- New therapies for alopecia areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management